PROCEPT BioRobotics Corporation increased revenue guidance for full year 2024. For the period, the Company projects revenue for the full year 2024 to be $213.5 million, which represents 57% growth over the Company?s prior year revenue. This compares to previous revenue guidance of $210.0 million.
PROCEPT BioRobotics Corporation
Equities
PRCT
US74276L1052
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.55 USD | -1.28% | -2.02% | +56.41% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.41% | 3.37B | |
-6.54% | 179B | |
-0.32% | 108B | |
-2.05% | 69.03B | |
-7.14% | 45.83B | |
+12.24% | 45.39B | |
+9.79% | 43.17B | |
+15.37% | 29.89B | |
+13.22% | 25.49B | |
-6.64% | 23.95B |
- Stock Market
- Equities
- PRCT Stock
- News PROCEPT BioRobotics Corporation
- Procept Biorobotics Corporation Increases Revenue Guidance for Full Year 2024